Showing 321 - 340 results of 232,184 for search '(( e fold decrease ) OR ( 10 ((((mean decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.69s Refine Results
  1. 321
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326
  7. 327
  8. 328
  9. 329

    Replication data set: Variability and correlations decrease during task states in human fMRI data. by Takuya Ito (57473)

    Published 2020
    “…<p>We successfully replicated results from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007983#pcbi.1007983.g003" target="_blank">Fig 3</a> using our held-out cohort of 176 subjects. …”
  10. 330

    Pioglitazone Decreases Hepatitis C Viral Load in Overweight, Treatment Naïve, Genotype 4 Infected-Patients: A Pilot Study by Mario Chojkier (82942)

    Published 2012
    “…Pioglitazone was effective in decreasing serum HCV RNA at day-14 (n = 10; difference of means = 205,618 IU/ml; 95% CI 26,600 to 384,600; <em>P</em><0.001). …”
  11. 331
  12. 332
  13. 333
  14. 334
  15. 335

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…The overall median rank of VRK1 mRNA overexpression was 947 (out of 19,273 measured genes) (p = 3.64x10<sup>-28</sup>). Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10<sup>-5</sup>), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10<sup>-5</sup>), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10<sup>-22</sup>), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10<sup>-71</sup>), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10<sup>-28</sup>), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10<sup>-12</sup>), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10<sup>-10</sup>) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10<sup>-17</sup>). …”
  16. 336

    Decreased miR-24 sensitizes cells to apoptotic stimuli, and increases pro-apoptotic protein expression. by Tan Nguyen (278146)

    Published 2013
    “…Infected cells were selected in puromycin and decreased expression of miR-24 validated by quantitative RT-PCR (<b><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0055406#pone.0055406.s004" target="_blank">Fig S4</a></b>). …”
  17. 337
  18. 338
  19. 339
  20. 340